Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi BiotecMiltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
navigation Sample preparation
navigation Cell separation
navigation Cell analysis
navigation Cell culture
navigation Molecular applications
Miltenyi Biotec
Miltenyi Links
Miltenyi Home
MACS Cytokines
MACS Cell Analysis
Tissue Dissociation
Neuroscience
Genomic Services
Miltenyi Biotec
CD73
Overview
The antibody is suitable for the identification and enumeration of human CD73+ cells by flow cytometry and fluorescence microscopy.
Details
Background information
The CD73 antigen is a 70 kDa membrane-bound enzyme that catalyzes the conversion of AMP to bioactive adenosine at neutral pH. This glycoprotein is also called ecto-5’-nucleotidase. CD73 is present on subsets of T and B lymphozytes, follicular dendritic cells, endothelial cells and marrow stromal cells (MSCs).1,2
Clone Isotype
AD2mouse IgG1
 
Human PBMCs were stained with CD73 antibodies conjugated to -PE (A) or APC (B) as well as with CD45-FITC and analyzed by flow cytometry using the MACSQuant® Analyzer. Cells stained with CD73-Biotin (C) were also stained with Anti-Biotin-PE.
A
B
C
Miltenyi Biotec
Search this website
Services
Customer login
Contact
Newsletter
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
CD73-PE, human
- for 100 tests (1)
Download datasheet
130-095-182
Qty.:
 

CD73-APC, human
- for 100 tests (1)
Download datasheet
130-095-183
Qty.:
 

CD73-Biotin, human
- for 100 tests (2)
Download datasheet
130-095-184
Qty.:
 

CD73 pure, human
- 100 µg in 1 mL
Download datasheet
130-095-185
Qty.:
 

(1) One test corresponds to fluorescent labeling of up to 107 cells in a total volume of 100 μL.
(2) One test corresponds to labeling of up to 107 cells in a total volume of 100 μL.
Related products
Mouse IgG1 - isotype control antibodies
References
1. Thomson, L.F. et al. (1990). Tissue Antigens 35: 9-19.
2. Pittenger, M.F. et al (1999) Science 284: 143-147.
MACS Stem Cell newsletter
Stay current with important developments in stem cell research by subscribing to Stem Cell Updates.
 
 
 
 
 
 
 
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website